![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LGALS1 |
Gene summary for LGALS1 |
![]() |
Gene information | Species | Human | Gene symbol | LGALS1 | Gene ID | 3956 |
Gene name | galectin 1 | |
Gene Alias | GAL1 | |
Cytomap | 22q13.1 | |
Gene Type | protein-coding | GO ID | GO:0001678 | UniProtAcc | P09382 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3956 | LGALS1 | GSM4909281 | Human | Breast | IDC | 6.11e-54 | 9.81e-01 | 0.21 |
3956 | LGALS1 | GSM4909282 | Human | Breast | IDC | 1.82e-08 | 5.09e-01 | -0.0288 |
3956 | LGALS1 | GSM4909285 | Human | Breast | IDC | 1.96e-37 | 7.73e-01 | 0.21 |
3956 | LGALS1 | GSM4909286 | Human | Breast | IDC | 6.66e-07 | -4.32e-01 | 0.1081 |
3956 | LGALS1 | GSM4909287 | Human | Breast | IDC | 7.07e-21 | 7.06e-01 | 0.2057 |
3956 | LGALS1 | GSM4909290 | Human | Breast | IDC | 3.03e-09 | 5.91e-01 | 0.2096 |
3956 | LGALS1 | GSM4909293 | Human | Breast | IDC | 4.86e-26 | -6.84e-01 | 0.1581 |
3956 | LGALS1 | GSM4909294 | Human | Breast | IDC | 5.75e-20 | -6.30e-01 | 0.2022 |
3956 | LGALS1 | GSM4909295 | Human | Breast | IDC | 8.72e-06 | 5.89e-01 | 0.0898 |
3956 | LGALS1 | GSM4909296 | Human | Breast | IDC | 1.77e-52 | 9.28e-01 | 0.1524 |
3956 | LGALS1 | GSM4909297 | Human | Breast | IDC | 9.27e-27 | 6.25e-01 | 0.1517 |
3956 | LGALS1 | GSM4909298 | Human | Breast | IDC | 9.67e-05 | 3.02e-01 | 0.1551 |
3956 | LGALS1 | GSM4909299 | Human | Breast | IDC | 1.10e-15 | 6.60e-01 | 0.035 |
3956 | LGALS1 | GSM4909302 | Human | Breast | IDC | 2.76e-24 | 7.22e-01 | 0.1545 |
3956 | LGALS1 | GSM4909303 | Human | Breast | IDC | 5.29e-04 | -5.28e-01 | 0.0438 |
3956 | LGALS1 | GSM4909304 | Human | Breast | IDC | 4.38e-47 | 7.72e-01 | 0.1636 |
3956 | LGALS1 | GSM4909307 | Human | Breast | IDC | 1.49e-19 | 6.41e-01 | 0.1569 |
3956 | LGALS1 | GSM4909308 | Human | Breast | IDC | 6.01e-10 | 4.84e-01 | 0.158 |
3956 | LGALS1 | GSM4909309 | Human | Breast | IDC | 2.13e-27 | 7.76e-01 | 0.0483 |
3956 | LGALS1 | GSM4909311 | Human | Breast | IDC | 1.83e-16 | -9.43e-02 | 0.1534 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0048524112 | Thyroid | PTC | positive regulation of viral process | 44/5968 | 65/18723 | 3.24e-09 | 8.76e-08 | 44 |
GO:0052126113 | Thyroid | PTC | movement in host environment | 91/5968 | 175/18723 | 2.41e-08 | 5.43e-07 | 91 |
GO:0050792113 | Thyroid | PTC | regulation of viral process | 85/5968 | 164/18723 | 8.33e-08 | 1.70e-06 | 85 |
GO:0010975110 | Thyroid | PTC | regulation of neuron projection development | 194/5968 | 445/18723 | 1.05e-07 | 2.08e-06 | 194 |
GO:004312226 | Thyroid | PTC | regulation of I-kappaB kinase/NF-kappaB signaling | 118/5968 | 249/18723 | 2.04e-07 | 3.63e-06 | 118 |
GO:000724926 | Thyroid | PTC | I-kappaB kinase/NF-kappaB signaling | 130/5968 | 281/18723 | 2.78e-07 | 4.80e-06 | 130 |
GO:004312320 | Thyroid | PTC | positive regulation of I-kappaB kinase/NF-kappaB signaling | 91/5968 | 186/18723 | 8.76e-07 | 1.33e-05 | 91 |
GO:1903900113 | Thyroid | PTC | regulation of viral life cycle | 72/5968 | 148/18723 | 1.49e-05 | 1.58e-04 | 72 |
GO:0044409113 | Thyroid | PTC | entry into host | 72/5968 | 151/18723 | 3.48e-05 | 3.29e-04 | 72 |
GO:0009743113 | Thyroid | PTC | response to carbohydrate | 111/5968 | 253/18723 | 3.77e-05 | 3.48e-04 | 111 |
GO:0034109112 | Thyroid | PTC | homotypic cell-cell adhesion | 47/5968 | 90/18723 | 4.81e-05 | 4.31e-04 | 47 |
GO:0046718112 | Thyroid | PTC | viral entry into host cell | 68/5968 | 144/18723 | 8.26e-05 | 7.00e-04 | 68 |
GO:0034284112 | Thyroid | PTC | response to monosaccharide | 99/5968 | 225/18723 | 8.42e-05 | 7.03e-04 | 99 |
GO:0045785112 | Thyroid | PTC | positive regulation of cell adhesion | 176/5968 | 437/18723 | 1.10e-04 | 8.83e-04 | 176 |
GO:00313459 | Thyroid | PTC | negative regulation of cell projection organization | 83/5968 | 186/18723 | 1.72e-04 | 1.32e-03 | 83 |
GO:1903902110 | Thyroid | PTC | positive regulation of viral life cycle | 19/5968 | 29/18723 | 2.02e-04 | 1.51e-03 | 19 |
GO:0009746112 | Thyroid | PTC | response to hexose | 94/5968 | 219/18723 | 3.62e-04 | 2.45e-03 | 94 |
GO:00109778 | Thyroid | PTC | negative regulation of neuron projection development | 63/5968 | 137/18723 | 3.70e-04 | 2.50e-03 | 63 |
GO:0009749111 | Thyroid | PTC | response to glucose | 91/5968 | 212/18723 | 4.44e-04 | 2.95e-03 | 91 |
GO:0001678110 | Thyroid | PTC | cellular glucose homeostasis | 72/5968 | 172/18723 | 3.58e-03 | 1.73e-02 | 72 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LGALS1 | SNV | Missense_Mutation | c.307G>T | p.Asp103Tyr | p.D103Y | P09382 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-A1-A0SI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
LGALS1 | SNV | Missense_Mutation | rs113281514 | c.8N>T | p.Cys3Phe | p.C3F | P09382 | protein_coding | tolerated(0.07) | benign(0.165) | TCGA-A2-A25A-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Cytoxan | SD |
LGALS1 | SNV | Missense_Mutation | c.62N>A | p.Arg21Gln | p.R21Q | P09382 | protein_coding | tolerated(0.16) | benign(0.007) | TCGA-A7-A26H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | PD | |
LGALS1 | SNV | Missense_Mutation | novel | c.259N>C | p.Glu87Gln | p.E87Q | P09382 | protein_coding | tolerated(0.05) | benign(0.131) | TCGA-BH-A2L8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | CR |
LGALS1 | SNV | Missense_Mutation | novel | c.55N>G | p.Arg19Gly | p.R19G | P09382 | protein_coding | tolerated(0.23) | benign(0.189) | TCGA-VS-A94Z-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
LGALS1 | SNV | Missense_Mutation | c.316G>A | p.Glu106Lys | p.E106K | P09382 | protein_coding | deleterious(0.04) | benign(0.113) | TCGA-AA-3814-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
LGALS1 | SNV | Missense_Mutation | c.128G>A | p.Cys43Tyr | p.C43Y | P09382 | protein_coding | tolerated(0.16) | possibly_damaging(0.897) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
LGALS1 | SNV | Missense_Mutation | rs111700736 | c.146N>A | p.Arg49His | p.R49H | P09382 | protein_coding | deleterious(0.04) | possibly_damaging(0.754) | TCGA-AX-A0IU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | carboplatin | SD |
LGALS1 | SNV | Missense_Mutation | novel | c.355N>G | p.Asn119Asp | p.N119D | P09382 | protein_coding | tolerated(0.71) | benign(0.005) | TCGA-95-7567-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD |
LGALS1 | SNV | Missense_Mutation | novel | c.299A>G | p.Lys100Arg | p.K100R | P09382 | protein_coding | tolerated(0.11) | benign(0.005) | TCGA-66-2778-01 | Lung | lung squamous cell carcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3956 | LGALS1 | KINASE, DRUGGABLE GENOME | US8703720, Reference Compound 2 | |||
3956 | LGALS1 | KINASE, DRUGGABLE GENOME | US8703720, 15 | |||
3956 | LGALS1 | KINASE, DRUGGABLE GENOME | US8703720, Reference Compound 1 |
Page: 1 |